ERT Medicines · UK public procurement notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)

Framework agreementGoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)

Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue

Awarded 24 May 2023no call for competition

What is being bought

Published requirement description

Supply of ERT medicines to NHS Scotland:

NP92617 (e) Velaglucerase alfa - VPRIV®

NP92617 (f) Idursulfase - Elaprase®

NP92617 (g) Agalsidase Alfa - Replagal®

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1The Framework Agreements are for the supply of ERT Medicines to NHS Scotland

The Framework Agreements are for the supply of ERT Medicines to NHS Scotland. The Framework Agreements have been awarded as single supplier framework agreements per line to one (1) Framework Participant.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Framework agreement
Who may use this agreement: Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 24 May 2023, 11:56 BST
Last source update: 24 May 2023, 11:56 BST
Authority reference: NP92619 (e-g)
FTS notice number: 2023/S 000-014762
Classification (CPV): Pharmaceutical products
Delivery area: Scotland (UKM)
Official registry OCID: ocds-h6vhtk-03cef7 Find a Tender

Why no open competition: The procurement falls outside the scope of application of the directive
Published justification: This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.

Review and risk notes

Review procedure: Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015. Total value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015. OJEU notice numbers for each of the individual Awards: NP92619(e)VPRIV®- 2019/S 170-415137 NP92619(f)Elaprase®- 2019/S 170-415114 NP92619(g)Replegal®- 2019/S 170-415138 (SC Ref:730595)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Suppliers appointed 1admitted to the panel · see the list ↓

Contracts signed 1latest 24 May 2023

1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

Contract 014762-2023-NP92619(e-g)-1
Signed
24 May 2023
Value
£1,941,975
Status
active

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authorityNHS & healthcareBody governed by public lawHealth Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact name, email

Dispute resolution & review bodies

Sheriff Court HouseReview body EdinburghContact email

Framework contractors & participating bidders

1 commercial party on the notice

Takeda UK LimitedFramework contractor Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Bucks, Scotland, HP10 0HH

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.